The HIV+ Tumor Molecular Characterization Project (HTMCP) will study 100 cases each of diffuse large B-cell lymphoma, lung cancer, and cervical cancer. The ultimate goal is to understand genetic differences between paired tumor types in HIV-positive and negative individuals, thereby allowing targeted disease treatment. The HTMCP project is currently accruing tissue samples for molecular characterization.
The BCR serves as the distribution center responsible for providing digital images for the central pathology consensus review of all cases for the HTMCP. The BCR will also collect and standardize clinical data for qualified cases, prior to uploading to the Office of Cancer Genomics’ (OCG) Data Coordinating Center.
Click here to visit the National Cancer Institute's Office of Cancer Genomics website for more details on the HTMCP.
Clinical Data forms for the HTMCP are available here for download.